1, 3-PBIT (dihydrobromide) Catalog No.:M22529-C and HCC1806 cells) treatment reduces

and HCC1806 cells) treatment reduces cell viability in a dose-dependent manner

CC1(C)[C@@H]2CC[C@]3(C)[C@H](C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@@]34C)C(O)=O)[C@@]2(C)CC[C@@H]1O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C(O)=O

CAS Number: 14494-37-2

LY411575 was usually used at 10 µM final concentration in vitro and in cellular assays

OC/C=C1\O[C@@H]2CC(=O)N2[C@H]\1C(=O)O[K]

1, 3-PBIT (dihydrobromide) Catalog No.:M22529-C and HCC1806 cells) treatment reduces1,3 PBIT (dihydrobromide) is a potent and selective iNOS inhibitor with Ki value of 47 nM . Nitric oxide (NO) is an endogenously produced inorganic free radical gas which has been implicated in blood pressure homeostasis, platelet aggregation, neurotransmission, and immunological defense mechanisms. NO is synthesized by three isoforms of nitric oxide synthase (NOS): nNOS, eNOS and iNOS . 1,3 PBIT, also known as S,S (1,3 Phenylenebis(1,2